ecancermedicalscience

Erratum

Erratum: RENATA study—Latin American prospective experience: clinical outcome of patients treated with palbociclib in hormone receptor-positive metastatic breast cancer—real-world use

7 Aug 2020
Fernando Petracci, Gonzalo Gomez Abuin, Alejandra Pini, Matías Chacón

On page 3, the number 72.5 in the following sentence replaces the number 37.5 which was incorrect:

'The Overall CB was 82.5%, higher in first line than in second line, 85.9% and 62.5%, respectively. The ORR in first line were: 4.7% CR, 40.6% PR and 40.6% SD. In second line the ORR were: 25% PR, 37.5% SD and no CR.'

Related Articles

M T Maria Tereza Nieto-Coronel, Daniela Shveid Gerson, Gian Karla Urey Cuellar, Navia-Bueno Ma Pilar, Maribel Marmol Casas
Ashutosh Mishra, Amit Kumar, Ajay Gogia, Chinmay Bagla, Gajendra Pandit, Jyoti Sharma, Jyoutishman Saikia, Rohan Kapoor, D N Sharma, Atul Batra, Surendra Saini, Supriya Mallick, Nishkarsh Gupta, Brajesh Ratre, Ruchi Rathore, Sandeep Mathur, Sunil Kumar, Suryanarayana Deo
Moushumi Suryavanshi, Prashant Mehta, Manoj Kumar, Saphalta Bhagmar, Vidit Kapoor, Dushyant Kumar, Sweta Mishra, Bhawna Chauhan
Maria Lucila González Donna, Eliza Ramirez Cabrera, Andrea Magali del Valle Ochelli, Lucia Ayala Albertini, Lucas Coradini, Verónica Alejandra Livieres Alayón, Iván Garrigoza Garcete, Cinthia Gauna Colas, Maria Luisa Cabañas León, Jabibi Noguera, Gladys Estigarribia, Alejandro Frydman, Carlos Palmes, Santiago Leguizamon, Matias Rodrigo Chacon, Federico Waisberg
Hafssa El Hilali, Nassiba Bahra, Sanae Guennouni, Chaymae Chbihi, Samia El Hakym, Diango Keita, Sara Nejjari, Abir Oufrid, Oumaima Siyouri, Lamiae Amaadour, Karima Oualla, Zineb Benbrahim, Touria Bouhafa, Nawfel Mellas, Samira El Fakir, Samia Arifi